Anesthetic Management of Awake Craniotomy for Resection of the Language and Motor Cortex Vascular Malformations.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
11 2020
Historique:
received: 26 05 2020
accepted: 09 07 2020
pubmed: 1 8 2020
medline: 18 5 2021
entrez: 1 8 2020
Statut: ppublish

Résumé

Although the safety and feasibility of awake craniotomy are well established for epilepsy and brain tumor surgery, its application for resection of vascular lesions, including arteriovenous malformations (AVMs) and cavernomas, is still limited. Apart from the usual challenges of awake craniotomy, vascular lesions pose several additional problems. Our goal is to determine the safety and practicality of awake craniotomy in patients with cerebral vascular malformations located near the eloquent areas, using a refined anesthetic protocol. A retrospective case series was performed on 7 patients who underwent awake craniotomy for resection of AVMs or cavernomas located in the eloquent language and motor areas. Our protocol consisted of achieving deep sedation, without a definitive airway, using a combination of propofol, dexmedetomidine, and remifentanil/fentanyl during scalp block placement and surgical exposure, then transitioning to a wakeful state during the resection. Six patients had intracranial AVMs, and 1 patient had a cavernoma. Six patients had complete resection; however, 1 patient underwent repeat awake craniotomy for residual AVM nidus. The patients tolerated the resection under continuous awake neurologic and neurophysiologic testing without significant perioperative complications or the need to convert to general anesthesia with a definitive airway. Awake craniotomy for excision of intracranial vascular malformations located near the eloquent areas, in carefully selected patients, can facilitate resection by allowing close neuromonitoring and direct functional assessment. A balanced combination of sedative and analgesic medications can provide both adequate sedation and rapid wakeup, facilitating the necessary patient interaction and tolerance of the procedure.

Sections du résumé

BACKGROUND
Although the safety and feasibility of awake craniotomy are well established for epilepsy and brain tumor surgery, its application for resection of vascular lesions, including arteriovenous malformations (AVMs) and cavernomas, is still limited. Apart from the usual challenges of awake craniotomy, vascular lesions pose several additional problems. Our goal is to determine the safety and practicality of awake craniotomy in patients with cerebral vascular malformations located near the eloquent areas, using a refined anesthetic protocol.
METHODS
A retrospective case series was performed on 7 patients who underwent awake craniotomy for resection of AVMs or cavernomas located in the eloquent language and motor areas. Our protocol consisted of achieving deep sedation, without a definitive airway, using a combination of propofol, dexmedetomidine, and remifentanil/fentanyl during scalp block placement and surgical exposure, then transitioning to a wakeful state during the resection.
RESULTS
Six patients had intracranial AVMs, and 1 patient had a cavernoma. Six patients had complete resection; however, 1 patient underwent repeat awake craniotomy for residual AVM nidus. The patients tolerated the resection under continuous awake neurologic and neurophysiologic testing without significant perioperative complications or the need to convert to general anesthesia with a definitive airway.
CONCLUSIONS
Awake craniotomy for excision of intracranial vascular malformations located near the eloquent areas, in carefully selected patients, can facilitate resection by allowing close neuromonitoring and direct functional assessment. A balanced combination of sedative and analgesic medications can provide both adequate sedation and rapid wakeup, facilitating the necessary patient interaction and tolerance of the procedure.

Identifiants

pubmed: 32736129
pii: S1878-8750(20)31571-0
doi: 10.1016/j.wneu.2020.07.050
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Anesthetics, Intravenous 0
Hypnotics and Sedatives 0
Dexmedetomidine 67VB76HONO
Remifentanil P10582JYYK
Fentanyl UF599785JZ
Propofol YI7VU623SF

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e136-e148

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Annie Ting Wang (AT)

Departments of Anesthesiology, Loma Linda University Medical Center, Loma Linda, California, USA.

Promod Pillai (P)

Departments of Neurological Surgery, Loma Linda University Medical Center, Loma Linda, California, USA.

Elyse Guran (E)

Departments of Anesthesiology, Loma Linda University Medical Center, Loma Linda, California, USA.

Harmony Carter (H)

Departments of Anesthesiology, Loma Linda University Medical Center, Loma Linda, California, USA.

Tanya Minasian (T)

Departments of Neurological Surgery, Loma Linda University Medical Center, Loma Linda, California, USA.

John Lenart (J)

Departments of Anesthesiology, Loma Linda University Medical Center, Loma Linda, California, USA.

Rashmi Vandse (R)

Departments of Anesthesiology, Loma Linda University Medical Center, Loma Linda, California, USA. Electronic address: RVandse@llu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH